COVID-19 A RANDOMIZED PHASE 2 CLINICAL TRIAL OF HIF ACTIVATOR VADADUSTAT FOR PREVENTION OR TREATMENT OF ARDS IN HOSPITALIZED COVID-19 PATIENTS

University Of Texas Health Science Center At Houston

Investigators